Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: Results of a randomized trial-Reference-Cited by-同舟云学术

Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: Results of a randomized trial

Published:2018-10-18 Issue:3 Volume:19 Page:811-822
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Tönshoff Burkhard¹,Ettenger Robert²,Dello Strologo Luca³,Marks Stephen D.⁴,Pape Lars⁵,Tedesco‐Silva Helio⁶,Bjerre Anna⁷,Christian Martin⁸,Meier Matthias⁹,Martzloff El‐Djouher⁹,Rauer Barbara⁹,Ng Jennifer¹⁰,Lopez Patricia⁹

Affiliation:

1. Department of Pediatrics I University Children's Hospital Heidelberg Heidelberg Germany

2. Division of Pediatric NephrologyUCLA Mattel Children’s HospitalLos AngelesCA USA

3. Nephrology Unit, Department of Pediatrics Institute for Scientific Research, Bambino Gesù Children's Hospital Rome Italy

4. Department of Paediatric Nephrology Great Ormond Street Hospital for Children NHS Foundation Trust London UK

5. Department of Pediatric Nephrology Hannover Medical School Hannover Germany

6. Nephrology Division Hospital do Rim, UNIFESP São Paulo Brazil

7. Division of Paediatric and Adolescent Medicine, Department of Pediatrics Oslo University Hospital Oslo Norway

8. Department of Paediatric NephrologyNottingham Children's Hospital Nottingham UK

9. Novartis Pharma AG Basel Switzerland

10. Biometrics and Statistical ScienceNovartis PharmaceuticalsEast HanoverNJ USA

Funder

Alexion Pharmaceuticals

Astellas Pharma US

Novartis

Roche

Eli Lilly and Company

Novo Nordisk

Raptor Research Foundation

Boehringer Ingelheim

Bristol-Myers Squibb

Sanofi

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15081

Reference38 articles.

1. The impact of calcineurin inhibitors on graft survival

2. The safety of calcineurin inhibitors for kidney-transplant patients

3. Everolimus-based calcineurin-inhibitor sparing regimens for kidney transplant recipients: a systematic review and meta-analysis

4. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

5. Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Pediatric Kidney Transplant Rejection: Its Pathophysiology, Biomarkers, and Management Strategies;Current Medicinal Chemistry;2024-08-12

2. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis;Transplantation Reviews;2024-07

3. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation;Transplantation;2024-04-12

4. Sirolimus in combination with low-dose extended-release tacrolimus in kidney transplant recipients;Frontiers in Medicine;2023-12-01

5. Validation of a prediction system for risk of kidney allograft failure in pediatric kidney transplant recipients: An international observational study;American Journal of Transplantation;2023-10